Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin in Pretreated Advanced Breast Cancer
NCT00246090Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by Eisai Co., Ltd.. Started Oct 2005; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00246090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246090.